Tetrabenazine

This classification denotes a dopamine antagonist with the molecular formula C19H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z9O08YRN8O, chemically known as 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2h-benzo(a)quinolizin-2-one but generally known as tetrabenazine, which bears US NIH Compound Identifier 6018. European Medicines Agency schedules Tetrabenazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10939MIG. The term TETRABENAZINE is an International Non-Proprietary Name. World Health Organization schedules tetrabenazine in its Anatomical Therapeutic Chemical (ATC) Classification. TETRABENAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tetrabenazine under HS 29339990 and SITC 51577. As of Q4 2014, TETRABENAZINE remains the US FDA Preferred Term for this commodity. Tetrabenazine bears US NLM identifiers UMLS ID C0039623 and NCI Concept Code C81095. SMILES: O=C1C(CN2C(C1)C1C(CC2)CC(OC)C(OC)C1)CC(C)C.